MGP
ABBV icon

M&G plc’s AbbVie ABBV Stock Holding History

M&G plc’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$146M Buy
579,447
+317,216
+121% +$68.2M 0.73% 40
2026
Q1 		$56.9M Buy
262,231
+9,286
+4% +$2.06M 0.29% 77
2025
Q4 		$57.7M Sell
252,945
-12,954
-5% -$2.95M 0.3% 78
2025
Q3 		$61.7M Sell
265,899
-22,406
-8% -$4.56M 0.33% 75
2025
Q2 		$53.6M Sell
288,305
-30,719
-10% -$5.71M 0.3% 85
2025
Q1 		$67M Sell
319,024
-70,152
-18% -$13.6M 0.32% 58
2024
Q4 		$69.3M Buy
389,176
+28,337
+8% +$5.21M 0.43% 62
2024
Q3 		$71.1M Sell
360,839
-3,983
-1% -$743K 0.26% 73
2024
Q2 		$62.7M Buy
364,822
+135,111
+59% +$22.4M 0.25% 70
2024
Q1 		$41.8M Buy
+229,711
New +$39.6M 0.16% 84

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

M&G plc's ABBV Position: Q2 2026 in Review

M&G plc increased its AbbVie (ABBV) stake by 121% in Q2 2026, buying an estimated $68.2M and bringing the position to 579,447 shares worth $146M. The position accounts for 0.73% of the portfolio, ranked #40.

M&G plc first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • M&G plc held 579,447 shares of AbbVie worth $146M as of Q2 2026.
  • M&G plc bought 317,216 AbbVie shares in Q2 2026, an estimated $68.2M.
  • AbbVie made up 0.73% of M&G plc's portfolio in Q2 2026, its #40 holding.
  • M&G plc first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • 4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on M&G plc's 13F filing for Q2 2026, filed 6 Aug 2026.